HE4 + ROMA Test

The HE4 + ROMA (Risk of Ovarian Malignancy Algorithm) test is designed to help detect ovarian cancer at an early stage. The test measures the levels of HE4 (Human Epididymis Protein 4) and combines these results with the patient’s CA 125 levels and menopausal status to calculate the ROMA score. This score is used to assess the risk of ovarian cancer, particularly in women presenting with pelvic masses or symptoms suggestive of ovarian malignancy.

HE4 + ROMA Test

  • Code: MLHER

Tests Included

HE4 is a protein that is often elevated in women with ovarian cancer. This marker is valuable for distinguishing between benign and malignant pelvic masses, especially when used in conjunction with other markers like CA 125.

The ROMA score combines the results of the HE4 test, CA 125 levels, and menopausal status to provide a risk assessment for ovarian cancer. This score is particularly useful for early detection and guiding further diagnostic steps.

HE4 + ROMA

FAQs

The HE4 + ROMA test is recommended for women who have symptoms of ovarian cancer, such as pelvic pain, bloating, or unexplained weight loss, or for those with a pelvic mass. It is particularly helpful for determining whether a mass is likely malignant and whether further diagnostic steps or surgery may be necessary.

A blood sample is taken from a vein in your arm. The levels of HE4 and CA 125 are measured, and your menopausal status is used to calculate the ROMA score.

Results are typically available within 1–2 working days. You will be notified by email or text once your results are ready.

No special preparation is required for the HE4 + ROMA test. However, it’s important to inform your healthcare provider about any ongoing treatments or medical conditions that might influence the test results.

Book Your HE4 + ROMA Test Today!

 

Get an early assessment for ovarian cancer with the HE4 + ROMA test. Take a proactive approach to your health and receive valuable insights into your risk of ovarian malignancy.

Contact Us

If the information you are looking for is not available here, please contact us. Additionally, follow us on our social media platforms for updates and more information:

 

LinkedIn Facebook X Instagram and YouTube.